Search Within

Philip O Livingston

Formats
  1. Journal Article (152)
  2. Meeting Abstract (65)
  3. Book Section (8)
  4. Conference Paper (3)
Groups
  1. Department of Medicine (161)
  2. Solid Tumor Oncology Division (157)
  3. Melanoma and Immunotherapeutics Service (148)
  4. Melanoma Disease Management Team (120)
  5. Sloan Kettering Institute Faculty (81)
  6. Molecular Pharmacology and Chemistry Program Faculty (53)

More Groups

People
  1. Govindaswami Ragupathi (118)
  2. Samuel Danishefsky (46)
  3. Kenneth Lloyd (32)
  4. Paul Chapman (30)
  5. Alan Houghton (28)
  6. Shengle Zhang (25)

More People

Years
  1. 2017 (1)
  2. 2014 (3)
  3. 2013 (1)
  4. 2012 (2)
  5. 2011 (8)
  6. 2010 (6)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (38)
  2. Cancer Research (25)
  3. Clinical Cancer Research (21)
  4. Cancer Immunology, Immunotherapy (18)
  5. International Journal of Cancer (12)
  6. Vaccine (11)

More Publications

Publishers
  1. American Association for Cancer Research (84)
  2. Springer (24)
  3. Elsevier Inc. (17)
  4. American Chemical Society (16)
  5. John Wiley & Sons (15)
  6. American Society of Clinical Oncology (10)

More Publishers

Results (228)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines
    Meeting Abstract

    Ragupathi, G.; Koide, F.; Yin, B.; Lloyd, K. O.; Hannaman, D.; Livingston, P. O.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Botanicals as immunological adjuvants and immunomodulators
    Meeting Abstract

    Livingston, P. O.; Hood, C.; Ragupathi, G.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Preclinical evaluation of fully synthetic Globo H cluster carbohydrate antigen as a cancer vaccine
    Meeting Abstract

    Koide, F.; Ragupathi, G.; Keding, S. J.; Allen, J.; Danishefsky, S. J.; Livingston, P. O.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Journal Article

    Sabbatini, P.; Dupont, J.; Aghajanian, C.; Derosa, F.; Poynor, E.; Anderson, S.; Hensley, M.; Livingston, P.; Iasonos, A.; Spriggs, D.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: A synthetic route to anticancer vaccine candidates
    Journal Article

    Ragupathi, G.; Koide, F.; Livingston, P. O.; Cho, Y. S.; Endo, A.; Wan, Q.; Spassova, M. K.; Keding, S. J.; Allen, J.; Ouerfelli, O.; more...
    Journal of the American Chemical Society (2006)

    Fulltext@MSK | Save
  • Cancer vaccines targeting carbohydrate antigens
    Journal Article

    Livingston, P. O.; Ragupathi, G.
    Human Vaccines (2006)

    Fulltext@MSK | Save
  • Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma
    Journal Article

    Hwu, W. J.; Panageas, K. S.; Menell, J. H.; Lamb, L. A.; Aird, S.; Krown, S. E.; Williams, L. J.; Chapman, P. B.; Livingston, P. O.; Wolchok, J. D.; more...
    Cancer (2006)

    Fulltext@MSK | Save
  • Preclinical evaluation of fully synthetic unimolecular penta-antigenic carbohydrate antigen as a cancer vaccine
    Meeting Abstract

    Ragupathi, G.; Koide, F.; Keding, S.; Allen, J.; Danishefsky, S. J.; Livingston, P. O.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • GM2, fucosyl GM1, globo H and polysialic acid are suitable targets for a tetravalent vaccine against SCLC
    Meeting Abstract

    Livingston, P.; Hood, C.; Krug, L. M.; Warren, N.; Kris, M. G.; Brezicka, T.; Ragupathi, G.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • GD2 antibodies prevent tumor recurrence after foot-pad challenge followed by amputation despite impact of micrometastases
    Meeting Abstract

    Koide, F.; Gathuru, J.; Kim, S. K.; Ragupathi, G.; Cheung, N. K.; Livingston, P. O.
    Cancer Research (2005)

    Fulltext@MSK | Save